Transforming Stem Cell Transplants

Startup licenses technologies that could transform treatment of blood diseases, immune disorders

Magenta Therapeutics

The startup is cofounded by stem cell scientist Professor David Scadden. X

Convening Leaders in Science and Business

First annual Harvard FUSION symposium probes the future of regenerative medicine

Convergence

FUSION is hosted by OTD's Blavatnik Biomedical Accelerator and the Blavatnik Fellowship in Life Science Entrepreneurship at HBS. X

Advancing Science, Harnessing Innovation

Six-year, $8.4M research alliance with Tata companies pioneers a new model of technology development

Leadership Development

Tata Fellows at HBS will collaborate with Harvard research teams to develop commercialization plans for arising technologies. X

Visualizing Gene Expression In Situ

New startup to commercialize FISSEQ technology that sequences and maps thousands of RNAs within cells and tissues

The Next "Next-Gen" Sequencing

FISSEQ technology may advance the development of diagnostics and the discovery of new drug targets. X

Accelerating Materials Discovery

Harvard licenses powerful molecular screening platform to Kyulux, developer of OLED display technologies

Molecular Design

“Our screening software has great potential to really change the nature of materials discovery in commercial R&D,” said Prof. Alán Aspuru-Guzik. X